clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2023-101-12-665-674clinmed-703Research ArticleЗАМЕТКИ И НАБЛЮДЕНИЯ ИЗ ПРАКТИКИNOTES AND OBSERVATIONS FROM PRACTICEТерапия нарушений ритма сердца, ассоциированных с инфекцией SARS-CoV-2, противовоспалительными средствамиTreatment of heart rhythm disturbances associated with SARS-CoV-2 infection with anti-inflammatory drugsСукмароваЗ. Н.SukmarovaZ. N.

Сукмарова Зульфия Наилевна — канд. мед. наук, научный сотрудник

115522, Москва

Zulfiya N. Sukmarova — Candidate of Medical Sciences, Researcher

115522, Moscow

suzulfia@gmail.comЗоткинЕ. Г.ZotkinE. G.

Зоткин Евгений Германович — д-р мед. наук, первый заместитель директора

115522, Москва

Evgeny G. Zotkin — Doctor of Medical Sciences, First Deputy Director

115522, Moscow

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation20232202202410112665674Copyright © Сукмарова З.Н., Зоткин Е.Г., 20242024Сукмарова З.Н., Зоткин Е.Г.Sukmarova Z.N., Zotkin E.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/703

Публикации, касающиеся нарушений ритма сердца, возникающих на фоне или вследствие новой коронавирусной инфекции (COVID-19), сосредоточены в основном на высокой распространенности и симптомах данного осложнения. Исследований, посвященных особенностям терапии аритмий, ассоциированных с SARS-CoV2, нами не найдено, так как, вероятно, подразумевается стандартный терапевтический подход. Данное наблюдение описывает серию случаев различных нарушений ритма сердца, возникших на фоне острой COVID-19 и купированных противовоспалительными, но не противоаритмическими препаратами. Случаи объединены возникновением на остроте заражения SARS-CoV-2, связью рецидивов с симптомами воспаления, а также эффективностью терапии основными классами противовоспалительных средств. В повествовательном обзоре литературы приводится обоснование воспалительной теории аритмий и создается почва для дискуссии о том, чтобы дифференцированно интегрировать противовоспалительные препараты в схему лечения подобных пациентов.

Publications regarding cardiac arrhythmias associated with the new coronavirus infection (COVID-19) focus primarily on the high prevalence and symptoms of this complication. We have not found any studies on the specific treatment of arrhythmias associated with SARS-CoV2, since a standard therapeutic approach is probably implied. This observation describes a series of cases of various cardiac arrhythmias that occurred against the background of acute COVID-19 and were treated with anti-inflammatory, but not antiarrhythmic drugs. The cases are united by the occurrence of acute SARS-CoV-2 infection, the connection of relapses with inflammation symptoms, as well as the effectiveness of therapy with the main classes of anti-inflammatory drugs. A narrative review of the literature provides the rationale for the inflammatory theory of arrhythmias and sets the stage for discussion about how to integrate differentially anti-inflammatory drugs into the treatment regimen of such patients.

COVID-19нарушения ритма сердцапротивовоспалительная терапияCOVID-19heart rhythm disturbancesanti-inflammatory therapyReferencesGranier M., Massin F., Pasquié J.L. Pro- and anti-arrhythmic effects of anti-inflammatory drugs. Antiinflamm Antiallergy Agents. Med. Chem. 2013;12(1):83–93. DOI: 10.2174/1871523011312010010Granier M., Massin F., Pasquié J.L. Pro- and anti-arrhythmic effects of anti-inflammatory drugs. Antiinflamm Antiallergy Agents. Med. Chem. 2013;12(1):83–93. DOI: 10.2174/1871523011312010010Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 2011;91(1):265–325. DOI: 10.1152/physrev.00031.2009Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 2011;91(1):265–325. DOI: 10.1152/physrev.00031.2009Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., Cooper L.T. Jr., Chahal C.A.A. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–1471. DOI: 10.1016/j.hrthm.2020.05.001Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., Cooper L.T. Jr., Chahal C.A.A. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–1471. DOI: 10.1016/j.hrthm.2020.05.001Сукмарова З., Мартыненко Т., Брыкля Е., Федорова Е. Перикардит как новый высокоспецифичный симптом SARS-CoV-2: исследование случай-контроль. Материалы конгресса «Радиология 2021».Sukmarova Z., Martynenko T., Bryklya E., Fedorova E. Pericarditis as a new highly specific symptom of SARS-CoV-2: a case-control study. Materials of the Congress “Radiology 2021” (In Russi an)Zhan Y., Yue H., Liang W., Wu Z. Effects of COVID-19 on arrhythmia. J. Cardiovasc. Dev. Dis. 2022;9(9):292. DOI: 10.3390/jcdd9090292Zhan Y., Yue H., Liang W., Wu Z. Effects of COVID-19 on arrhythmia. J. Cardiovasc. Dev. Dis. 2022;9(9):292. DOI: 10.3390/jcdd9090292Coromilas E.J., Kochav S., Goldenthal I., Biviano A., Garan H., Goldbarg S., Kim J.H., Yeo I., Tracy C., Ayanian S. et al. Worldwide survey of COVID-19 Associated Arrhythmias. Circ. Arrhythm. Electrophysiol. 2021;14:e009458. DOI: 10.1161/CIRCEP.120.009458Coromilas E.J., Kochav S., Goldenthal I., Biviano A., Garan H., Goldbarg S., Kim J.H., Yeo I., Tracy C., Ayanian S. et al. Worldwide survey of COVID-19 Associated Arrhythmias. Circ. Arrhythm. Electrophysiol. 2021;14:e009458. DOI: 10.1161/CIRCEP.120.009458Cavigli L., Frascaro F., Turchini F., Mochi N., Sarto P., Bianchi S., Parri A., Carraro N., Valente S., Focardi M. et al. A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play. Int. J. Cardiol. 2021;336:130–136. DOI: 10.1016/j.ijcard.2021.05.042Cavigli L., Frascaro F., Turchini F., Mochi N., Sarto P., Bianchi S., Parri A., Carraro N., Valente S., Focardi M. et al. A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play. Int. J. Cardiol. 2021;336:130–136. DOI: 10.1016/j.ijcard.2021.05.042Musika ntow D.R., Turagam M.K., Sartori S. et al. Atrial fibrillation in patients hospitalized with COVID-19: incidence, predictors, outcomes, and comparison to influenza. JACC Clin. Electrophysiol. 2021;7(9):1120–1130. DOI: 10.1016/j.jacep.2021.02.009Musika ntow D.R., Turagam M.K., Sartori S. et al. Atrial fibrillation in patients hospitalized with COVID-19: incidence, predictors, outcomes, and comparison to influenza. JACC Clin. Electrophysiol. 2021;7(9):1120–1130. DOI: 10.1016/j.jacep.2021.02.009Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C. et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28:410–422. DOI: 10.1038/s41591-021-01630-0Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C. et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28:410–422. DOI: 10.1038/s41591-021-01630-0Sangpornsuk N., Rungpradubvong V., Tokavanich N., Srisomwong S., Ananwattanasuk T., Teerawongsakul P., Kerr S.J., Su wanwalaikorn M., Jongnarangsin K., Chokesuwattanaskul R. Arrhythmias after SARS-CoV-2 Vaccination in Patients with a Cardiac Implantable Electronic Device: A Multicenter Study. Biomedicines. 2022;10:2838. DOI: 10.3390/biomedicines10112838Sangpornsuk N., Rungpradubvong V., Tokavanich N., Srisomwong S., Ananwattanasuk T., Teerawongsakul P., Kerr S.J., Su wanwalaikorn M., Jongnarangsin K., Chokesuwattanaskul R. Arrhythmias after SARS-CoV-2 Vaccination in Patients with a Cardiac Implantable Electronic Device: A Multicenter Study. Biomedicines. 2022;10:2838. DOI: 10.3390/biomedicines10112838Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P. et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283–288. DOI: 10.1038/s41586-021-03631-yWang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P. et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283–288. DOI: 10.1038/s41586-021-03631-yBlagova O., Varionchik N., Zaidenov V., Savina P., Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur. J. Immunol. 2021;51:893–902. DOI: 10.1002/eji.202048930Blagova O., Varionchik N., Zaidenov V., Savina P., Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur. J. Immunol. 2021;51:893–902. DOI: 10.1002/eji.202048930Friedrichs K., Klinke A., Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol. Med. 2011;17(10):556–563. DOI: 10.1016/j.molmed.2011.05.007Friedrichs K., Klinke A., Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol. Med. 2011;17(10):556–563. DOI: 10.1016/j.molmed.2011.05.007Lazzerini P.E., Capecchi P.L., Laghi-Pasini F. Systemic inflammation and arrhythmic risk: Lessons from rheumatoid arthritis. Eur. Heart J. 2017;38:1717–1727. DOI: 10.1093/eurheartj/ehw208Lazzerini P.E., Capecchi P.L., Laghi-Pasini F. Systemic inflammation and arrhythmic risk: Lessons from rheumatoid arthritis. Eur. Heart J. 2017;38:1717–1727. DOI: 10.1093/eurheartj/ehw208Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., Stamatelopoulos K., Terpos E., Kotanidou A., Hagberg C.A. et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J. Infect. 2021;83:1–16. DOI: 10.1016/j.jinf.2021.05.004Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., Stamatelopoulos K., Terpos E., Kotanidou A., Hagberg C.A. et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J. Infect. 2021;83:1–16. DOI: 10.1016/j.jinf.2021.05.004Ryu K., Li L., Khrestian C.M., Matsumoto N., Sahadevan J., Ruehr M.L., Van Wagoner D.R., Efimov I.R., Waldo A.L. Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 2007;293(2):H1231–41. DOI: 10.1152/ajpheart.00607.2006Ryu K., Li L., Khrestian C.M., Matsumoto N., Sahadevan J., Ruehr M.L., Van Wagoner D.R., Efimov I.R., Waldo A.L. Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 2007;293(2):H1231–41. DOI: 10.1152/ajpheart.00607.2006Maesen B., Nijs J., Maessen J., Allessie M., Schotten U. Postoperative atrial fibrillation: a maze of mechanisms. Europace. 2012;14(2):159–174. DOI: 10.1093/europace/eur208Maesen B., Nijs J., Maessen J., Allessie M., Schotten U. Postoperative atrial fibrillation: a maze of mechanisms. Europace. 2012;14(2):159–174. DOI: 10.1093/europace/eur208Махнырь Е.Ф., Голоухова Л.М., Головко Е.В. Нарушения ритма сердца у больных ревматоидным артритом как проявление ревматоидной болезни сердца. Вестник РГМУ. 2009;7:45–8.Makhnir EF, Goloukhova LM, Golovko EV. Violations of a rhythm of heart at patients with rheumatoid arthritis as display of a rheumatoid heart trouble. Bulletin of the Russian state medical university. 2009;7:45–8. (In Russian)Новикова Д.С., Попкова Т.В., Герасимов А.Н., Волков А.В., Насонов Е.Л. Безболевая ишемия миокарда и нарушения ритма сердца у женщин с ревматоидным артритом. Клиницист. 2013;7(3–4):31–39. DOI: 10.17650/1818-8338-2013-3-4-31-39Novikova D.S., Popkova T.V., Gerasimov A.N., Volkov A.V., Nasonov E.I. Silent myocardial ischemia and cardiac rhythm disturbances in women with rheumatoid arthritis. The Clinician. 2013;7(3–4):31–39. (In Russian) DOI: 10.17650/1818-8338-2013-3-4-31-39Peretto G., Sala S., Rizzo S., Palmisano A., Esposito A., De Cobelli F., Campochiaro C., De Luca G., Foppoli L., Dagna L., Thiene G., Basso C., Della Bella P. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. J. Am. Coll. Cardiol. 2020;75(9):1046–1057. DOI: 10.1016/j.jacc.2020.01.036Peretto G., Sala S., Rizzo S., Palmisano A., Esposito A., De Cobelli F., Campochiaro C., De Luca G., Foppoli L., Dagna L., Thiene G., Basso C., Della Bella P. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. J. Am. Coll. Cardiol. 2020;75(9):1046–1057. DOI: 10.1016/j.jacc.2020.01.036Tian S., Xiong Y., Liu H., Niu L., Guo J., Liao M., Xiao S.Y. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod. Pathol. 2020;33(6):1007–1014. DOI: 10.1038/s41379-020-0536-xTian S., Xiong Y., Liu H., Niu L., Guo J., Liao M., Xiao S.Y. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod. Pathol. 2020;33(6):1007–1014. DOI: 10.1038/s41379-020-0536-xDisertori M., Rigoni M., Pace N., Casolo G., Mase M., Gonzini L., Lucci D., Nollo G., Ravelli F. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. JACC Cardiovasc. Imaging. 2016;9:1046–1055. DOI: 10.1016/j.jcmg.2016.01.033Disertori M., Rigoni M., Pace N., Casolo G., Mase M., Gonzini L., Lucci D., Nollo G., Ravelli F. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. JACC Cardiovasc. Imaging. 2016;9:1046–1055. DOI: 10.1016/j.jcmg.2016.01.033Сукмарова З.Н., Саидова М.А., Овчинников Ю.В. Экссудативный перикардит в патогенезе нарушений ритма сердца при COVID-19: серия клинических случаев. Кардиоваскулярная терапия и профилактика. 2022;21(2):3021. DOI: 10.15829/1728-8800-2022-3021Sukmarova Z.N., Saidova M.A., Ovchinnikov Yu.V. Exudative pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a series of clinical cases. Cardiovascular therapy and prevention. 2022;21(2):3021. (In Russian) DOI: 10.15829/1728-8800-2022-3021Сукмарова З.Н., Овчинников Ю.В., Ларина О.М., Лепендин С.О., Афонина О.В., Громов А.И. Отрыв хорд митрального клапана у высокотренированных мужчин в ранние сроки после COVID-19. Серия клинических случаев. Спортивная медицина: наука и практика. 2022;12(1):77–85. DOI: 10.47529/2223-2524.2022.1.2Sukmarova Z.N., Ovchinnikov Yu.V., Larina O.M., Lependin S.O., Afonina O.V., Gromov A.I. Mitral valve chordae avulsion in highly trained men early after COVID-19. A clinical cases series. Sports medicine: science and practice. 2022;12(1):77–85. (In Russian) DOI: 10.47529/2223-2524.2022.1.2Pagé P.L., Plumb V.J., Okumura K., Waldo A.L. A new animal model of atrial flutter. J. Am. Coll. Cardiol. 1986;8(4):872–879. DOI: 10.1016/s0735-1097(86)80429-6.11.Pagé P.L., Plumb V.J., Okumura K., Waldo A.L. A new animal model of atrial flutter. J. Am. Coll. Cardiol. 1986;8(4):872–879. DOI: 10.1016/s0735-1097(86)80429-6.11.Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G., van Hardevelt F.W., de Beaumont E.M., Wildevuur C.R., Eijsman L., Trouwborst A., Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96(10):3542–3548. DOI: 10.1161/01.cir.96.10.3542Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G., van Hardevelt F.W., de Beaumont E.M., Wildevuur C.R., Eijsman L., Trouwborst A., Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96(10):3542–3548. DOI: 10.1161/01.cir.96.10.3542Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006–3010. DOI: 10.1161/01.CIR.0000103131.70301.4FAviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006–10. DOI: 10.1161/01.CIR.0000103131.70301.4FMyocardial Infl ammation/Myocarditis After COVID-19 mRNA Booster Vaccination. C. Mueller. Oral presentation. URL: https://esc365.escardio.org/presentation/25541412.Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination. C. Mueller. Oral presentation. URL: https://esc365.escardio.org/presentation/25541412.Сукмарова З.Н., Овчинников Ю.В., Гудима Г.О., Ибрагимова Ф.М., Афонина О.В., Мачкалян К.Э. Усиление эхо-сигнала от перикарда у реципиентов вакцин против SARS-CoV-2. Инфекционные болезни. 2021;19(4):43–50. DOI: 10.20953/1729-9225-2021-4-43-50Sukmarova Z.N., Ovchinnikov Yu.V., Gudima G.O., Ibragimova F.M., Afonina O.V., Machkalyan K.E. Increased pericardial echogenity in recipients of SARS-CoV-2 vaccines. Infectious diseases. 2021;19(4):43–50. (In Russian) DOI: 10.20953/1729-9225-2021-4-43-50Ho K.M., Tan J.A. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation. 2009;119(14):1853–66. DOI: 10.1161/CIRCULATIONAHA.108.848218Ho K.M., Tan J.A. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation. 2009;119(14):1853–1866. DOI: 10.1161/CIRCULATIONAHA.108.848218De Caterina R., Ruigómez A., Rodríguez L.A. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch. Intern. Med. 2010;170(16):1450–1455. DOI: 10.1001/archinternmed.2010.305De Caterina R., Ruigómez A., Rodríguez L.A. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch. Intern. Med. 2010;170(16):1450–1455. DOI: 10.1001/archinternmed.2010.305Ammirati E., Frigerio M., Adler E.D., Basso C., Birnie D.H., Brambatti M., Friedrich M.G., Klingel K., Lehtonen J., Moslehi J.J., Pedrotti P., Rimoldi O.E., Schultheiss H.P., Tschöpe C., Cooper L.T. Jr, Camici P.G. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ. Heart Fail. 2020;13(11):e007405. DOI: 10.1161/CIRCHEARTFAILURE.120.007405Ammirati E., Frigerio M., Adler E.D., Basso C., Birnie D.H., Brambatti M., Friedrich M.G., Klingel K., Lehtonen J., Moslehi J.J., Pedrotti P., Rimoldi O.E., Schultheiss H.P., Tschöpe C., Cooper L.T. Jr, Camici P.G. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ. Heart Fail. 2020;13(11):e007405. DOI: 10.1161/CIRCHEARTFAILURE.120.007405Nidorf S.M., Fiolet A.T.L., Mosterd A., Eikelboom J.W., Schut A., Opstal T.S.J., The S.H.K., Xu X.F., Ireland M.A., Lenderink T., Latchem D., Hoogslag P., Jerzewski A., Nierop P., Whelan A., Hendriks R., Swart H., Schaap .J, Kuijper A.F.M., van Hessen M.W.J., Saklani P., Tan I., Thompson A.G., Morton A., Judkins C., Bax W.A., Dirksen M., Alings M., Hankey G.J., Budgeon C.A., Tijssen J.G.P., Cornel J.H., Thompson P.L.; LoDoCo2 Trial investigators. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 2020;383(19):1838–1847. DOI: 10.1056/NEJMoa2021372Nidorf S.M., Fiolet A.T.L., Mosterd A., Eikelboom J.W., Schut A., Opstal T.S.J., The S.H.K., Xu X.F., Ireland M.A., Lenderink T., Latchem D., Hoogslag P., Jerzewski A., Nierop P., Whelan A., Hendriks R., Swart H., Schaap .J, Kuijper A.F.M., van Hessen M.W.J., Saklani P., Tan I., Thompson A.G., Morton A., Judkins C., Bax W.A., Dirksen M., Alings M., Hankey G.J., Budgeon C.A., Tijssen J.G.P., Cornel J.H., Thompson P.L.; LoDoCo2 Trial investigators. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 2020;383(19):1838–1847. DOI: 10.1056/NEJMoa2021372Bouabdallaoui N., Tardif J.C., Waters D.D., Pinto F.J., Maggioni A.P., Diaz R., Berry C., Koenig W., Lopez-Sendon J., Gamra H., Kiwan G.S., Blondeau L., Orfanos A., Ibrahim R., Grégoire J.C., Dubé M.P., Samuel M., Morel O., Lim P., Bertrand O.F., Kouz S., Guertin M.C., L’Allier P.L., Roubille F. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur. Heart J. 2020;41(42):4092–4099. DOI: 10.1093/eurheartj/ehaa659Bouabdallaoui N., Tardif J.C., Waters D.D., Pinto F.J., Maggioni A.P., Diaz R., Berry C., Koenig W., Lopez-Sendon J., Gamra H., Kiwan G.S., Blondeau L., Orfanos A., Ibrahim R., Grégoire J.C., Dubé M.P., Samuel M., Morel O., Lim P., Bertrand O.F., Kouz S., Guertin M.C., L’Allier P.L., Roubille F. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur. Heart J. 2020;41(42):4092–4099. DOI: 10.1093/eurheartj/ehaa659Сукмарова З.Н., Симоненко В.Б., Насонов Е.Л. Терапия перикардита колхицином, антагонистами интерлейкина-1, иммуносупрессантами. Клиническая медицина. 2023;101(1):6–17. DOI: 10.30629/0023-2149-2023-101-1-6-17Sukmarova Z.N., Simonenko V.B., Nasonov E.L. Treatment of pericarditis with colchicine, interleukin-1 antagonists, immuno suppressants. Clinical medicine. 2023;101(1):6–17. (In Russian) DOI: 10.30629/0023-2149-2023-101-1-6-17Bakele M., Joos M., Burdi S., Allgaier N., Pöschel S., Fehren bacher B., Schaller M., Marcos V., Kümmerle-Deschner J., Rieber N., Borregaard N., Yazdi A., Hector A., Hartl D. Localization and functionality of the inflammasome in neutrophils. J. Biol. Chem. 2014;289(8):5320–5329. DOI: 10.1074/jbc.M113.505636Bakele M., Joos M., Burdi S., Allgaier N., Pöschel S., Fehren bacher B., Schaller M., Marcos V., Kümmerle-Deschner J., Rieber N., Borregaard N., Yazdi A., Hector A., Hartl D. Localization and functionality of the inflammasome in neutrophils. J. Biol. Chem. 2014;289(8):5320–5329. DOI: 10.1074/jbc.M113.505636Imazio M., Brucato A., Ferrazzi P., Pullara A., Adler Y., Barosi A., Caforio A.L., Cemin R., Chirillo F., Comoglio C., Cugola D., Cumetti D., Dyrda O., Ferrua S., Finkelstein Y., Flocco R., Gandino A., Hoit B., Innocente F., Maestroni S., Musumeci F., Oh J., Pergolini A., Polizzi V., Ristic A., Simon C., Spodick D.H., Tarzia V., Trimboli S., Valenti A., Belli R., Gaita F; COPPS-2 Investigators. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016–1023. DOI: 10.1001/jama.2014.11026Imazio M., Brucato A., Ferrazzi P., Pullara A., Adler Y., Barosi A., Caforio A.L., Cemin R., Chirillo F., Comoglio C., Cugola D., Cumetti D., Dyrda O., Ferrua S., Finkelstein Y., Flocco R., Gandino A., Hoit B., Innocente F., Maestroni S., Musumeci F., Oh J., Pergolini A., Polizzi V., Ristic A., Simon C., Spodick D.H., Tarzia V., Trimboli S., Valenti A., Belli R., Gaita F; COPPS-2 Investigators. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fi brillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016–1023. DOI: 10.1001/jama.2014.11026Imazio M., Brucato A., Ferrazzi P., Rovere M.E., Gandino A., Cemin R., Ferrua S., Belli R., Maestroni S., Simon C., Zingarelli E., Barosi A., Sansone F., Patrini D., Vitali E., Trinchero R., Spodick D.H., Adler, Y. Investigators, C. Colchi cine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–2295. DOI: 10.1161/CIRCULATIONAHA.111.026153Imazio M., Brucato A., Ferrazzi P., Rovere M.E., Gandino A., Cemin R., Ferrua S., Belli R., Maestroni S., Simon C., Zingarelli E., Barosi A., Sansone F., Patrini D., Vitali E., Trinchero R., Spodick D.H., Adler, Y. Investigators, C. Colchi cine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–2295. DOI: 10.1161/CIRCULATIONAHA.111.026153Shvartz V., Le T., Enginoev S., Sokolskaya M., Ispiryan A., Shvartz E., Nudel D., Araslanova N., Petrosyan A., Donakanyan S., Chernov I., Bockeria L., Golukhova E. Colchicine in Cardiac Surgery: The COCS randomized clinical trial. J. Cardiovasc. Dev. Dis. 2022;9(10):363. DOI: 10.3390/jcdd9100363Shvartz V., Le T., Enginoev S., Sokolskaya M., Ispiryan A., Shvartz E., Nudel D., Araslanova N., Petrosyan A., Donakanyan S., Chernov I., Bockeria L., Golukhova E. Colchicine in Cardiac Surgery: The COCS randomized clinical trial. J. Cardiovasc. Dev. Dis. 2022;9(10):363. DOI: 10.3390/jcdd9100363Сукмарова З.Н., Симоненко В.Б., Насонов Е.Л. Лечение больных перикардитом противовоспалительными средствами. Клиническая медицина. 2022;100(11–12):509–519. DOI: 10.30629/0023-2149-2022-100-11-12-509-519Sukmarova Z.N., Simonenko V.B., Nasonov E.L. Treatment of pericarditis with anti-inflammatory drugs. Clinical medicine. 2022;100(11–12):509–519. (In Russian) DOI: 10.30629/0023-2149-2022-100-11-12-509-519Zhang J., Ding E.L., Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA. 2006;296(13):1619–1632. DOI: 10.1001/jama.296.13.jrv60015Zhang J., Ding E.L., Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA. 2006;296(13):1619–1632. DOI: 10.1001/jama.296.13.jrv60015Schmidt M., Christiansen C.F., Mehnert F., Rothman K.J., Sørensen H.T. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ. 2011;343:d3450. DOI: 10.1136/bmj.d3450Schmidt M., Christiansen C.F., Mehnert F., Rothman K.J., Sørensen H.T. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ. 2011;343:d3450. DOI: 10.1136/bmj.d3450Kearney P.M., Baigent C., Godwin J., Halls H., Emberson J.R., Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302–1328. DOI: 10.1136/bmj.332.7553.1302Kearney P.M., Baigent C., Godwin J., Halls H., Emberson J.R., Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302–1328. DOI: 10.1136/bmj.332.7553.1302Rosenberg E.S., Dufort E.M., Udo T., Wilberschied L.A., Kumar J., Tesoriero J., Weinberg P., Kirkwood J., Muse A., DeHovitz J., Blog D.S., Hutton B., Holtgrave D.R., Zucker H.A. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA. 2020;323(24):2493–2502. DOI: 10.1001/jama.2020.8630Rosenberg E.S., Dufort E.M., Udo T., Wilberschied L.A., Kumar J., Tesoriero J., Weinberg P., Kirkwood J., Muse A., DeHovitz J., Blog D.S., Hutton B., Holtgrave D.R., Zucker H.A. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA. 2020;323(24):2493–2502. DOI: 10.1001/jama.2020.8630

The authors declare that there are no conflicts of interest present.